Emotional expression in children treated with ADHD medication: Development of a new measure

Journal of Attention Disorders

Volumn 11, Issue 5, 2008, Pages 568-579

  Perwien, Amy R ^a,e   Kratochvil, Christopher J ^b   Faries, Douglas ^a   Vaughan, Brigette ^b   Busner, Joan ^c   Saylor, Keith E ^d   Buermeyer, Curtis M ^d   Kaplan, Stuart ^c   Swindle, Ralph ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d Neuroscience Inc

^e NONE   (United States)

Author keywords

ADHD medication; Children; Emotional expression; Measure development; Side effects

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

AFFECT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; EMOTION; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; PILOT STUDY; PSYCHOMETRY; QUESTIONNAIRE; VALIDATION STUDY;

AFFECT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; EXPRESSED EMOTION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PILOT PROJECTS; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 38849085905     PISSN: 10870547     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087054707306117     Document Type: Article

References (48)

1. Achenbach, T.M., & Rescorla, L.A. (2001). Manual for the ASEBA school-age forms and profiles. Burlington, VT: Research Center for Children, Youth, and Families.
2. American Academy of Child and Adolescent Psychiatry. (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 26S - 49S.
3. American Academy of Pediatrics Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. (2001). Clinical practice guideline: Treatment of the school-age child with attention-deficit/ hyperactivity disorder. Pediatrics, 108, 1033-1044.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4 th ed.). Washington, DC: Author.
5. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4 th ed., text revision). Washington, DC: Author.
6. Bagwell, C.L., Molina, B.S., Pelham, W.E., & Hoza, B. (2001). Attention-deficit hyperactivity disorder and problems in peer relations: Predictions from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1285-1292.
7. Biederman, J., Faraone, S.V., Monuteaux, M.C., & Grossbard, J.R. (2004). How informative are parent reports of attention-deficit/ hyperactivity disorder symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents' and teachers' reports. Pediatrics, 113, 1667-1671.
8. Biederman, J., Gao, H., Rogers, A.K., & Spencer, T.J. (2006). Comparison of parent and teacher reports of attention-deficit/ hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children. Biological Psychiatry, 60, 1106-1110.
9. Buhrmester, D., Whalen, C.K., Henker, B., MacDonald, V., & Hinshaw, S.P. (1992). Prosocial behavior in hyperactive boys: Effects of stimulant medication and comparison with normal boys. Journal of Abnormal Child Psychology, 20, 103-121.
10. Chan, E., Zhan, C., & Homer, C.J. (2002). Health care use and costs for children with attention-deficit/hyperactivity disorder: National estimates from the medical expenditure panel survey. Archives of Pediatric and Adolescent Medicine, 156, 504-511.
11. Collett, B.R., Ohan, J.L., & Myers, K.M. (2003). Ten-year review of rating scales. V: Scales assessing attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1015-1037.
12. Conners, C.K. (2000). Conners' Rating Scales-Revised: Technical manual. North Tonawanda, NY: Multi-Health Systems.
13. Conners, C.K., March, J.S., Frances, A., Wells, K.C., & Ross, R. (2001). Treatment of attention-deficit/hyperactivity disorder: Expert consensus guidelines. Journal of Attention Disorders, 4, S7 - S34.
14. DeVillis, R.F. (1991). Scale development: Theory and applications. Thousand Oaks, CA: Sage.
15. Doerfler, L.A., Felner, R.D., Rowlison, R.T., Raley. P. A., & Evans, E. (1988). Depression in children and adolescents: A comparative analysis of the utility and construct validity of two measures. Journal of Consulting and Clinical Psychology, 56, 769-772.
16. Doherty, S.L., Frankenberger, W., & Fuhrer, R. (2000). Children's self-reported effects of stimulant medication. International Journal of Disability, Development and Education, 47, 39-54.
17. Faraone, S.V., Biederman, J., Monuteaux, M.C., Doyle, A.E., & Seidman, L.J. (2001). A psychometric measure of learning disability predicts educational failure four years later in boys with attention-deficit/ hyperactivity disorder. Journal of Attention Disorders, 4, 220-230.
18. Granger, D.A., Whalen, C.K., & Henker, B. (1993). Perceptions of methylphenidate effects on hyperactive children's peer interactions. Journal of Abnormal Child Psychology, 21, 535-549.
19. Greene, R.W., Biederman, J., Faraone, S.V., Monuteaux, M.C., Mick, E., DuPre, E.P., et al. (2001). Social impairment in girls with ADHD: Patterns, gender comparisons, and correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 704-710.
20. Greenhill, L., Pliszka, S., Dulcan, M.K., Bernet, W., Arnold, V., Beitchman, J., et al. (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 26S - 49S.
21. Guevara, J., Lozano, P., Wickizer, T., Mell, L., & Gephart, H. (2001). Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics, 108, 71-78.
22. Harrison, C., & Sofronoff, K. (2002). ADHD and parental psychological distress: Role of demographics, child behavioral characteristics, and parental cognitions. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 703-711.
23. Johnson, J.H., & Reader, S.K. (2002). Assessing stress in families of children with ADHD: Preliminary development of the Disruptive Behavior Stress Inventory (DBSI). Journal of Clinical Psychology in Medical Settings, 9, 51-62.
24. Johnston, C., & Mash, E.J. (2001). Families of children with attention-deficit/hyperactivity disorder: Review and recommendations for future research. Clinical Child and Family Psychology Review, 4, 183-207.
25. Knight, D., Hensley, V.R., & Waters, B. (1988). Validation of the Children's Depression Scale and the Children's Depression Inventory in a prepubertal sample. Journal of Child Psychology Psychiatry and Allied Disciplines, 29, 853-863.
26. Kovacs, M. (1992). Children's Depression Inventory (CDI) manual. North Tonawanda, NY: Multi-Health Systems.
27. Kratochvil, C.J., Faries, D., Vaughan, B., Perwien, A.R., Busner, J., Saylor, K., et al. (2004, October). Emotional expression during ADHD treatment: Initial assessment of treatment effects. Poster session presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Ontario, Canada.
28. Kratochvil, C.J., Vaughan, B.S., Harrington, M.J., & Burke, W.J. (2003). Atomoxetine: A selective nonadrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Pharmacotherapy, 4, 1165-1174.
29. Leibson, C.L., Katusic, S.K., Barbaresi, W.J., Ranson, J., & O' Brien, P.C. (2001). Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 285, 53-66.
30. Lessler, J.T., & Forsyth, B.H. (1996). A coding system for appraising questionnaires. In N. Schwarz & S. Sudman (Eds.), Answering questions: Methodology for determining cognitive and communicative process in survey research (pp. 259-292). San Francisco: Jossey-Bass.
31. March, J.S., Parker, J.D., Sullivan, K., Stallings, P., & Conners, C.K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 554-565.
32. March, J.S., & Sullivan, K. (1999). Test-retest reliability of the Multidimensional Anxiety Scale for Children. Journal of Anxiety Disorders, 13, 349-358.
33. Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F.R., et al. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics, 108, e83.
34. Mitsis, E.M., McKay, K.E., Schulz, K.P., Newcorn, J.H., & Halperin, J.M. (2000). Parent-teacher concordance for DSM-IV attention-deficit/ hyperactivity disorder in a clinic-referred sample. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 308-313.
35. MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
36. Pastor, P.N., & Reuben, C.A. (2002). Attention deficit disorder and learning disability: United States, 1997-1998. Vital Health Statistics, 10, 1-11.
37. Pelham, W.E., Milich, R., Murphy, D.S., & Murphy, H. (1989). Normative data on the IOWA Conners Teacher Rating Scale. Journal of Clinical Child and Adolescent Psychology, 18, 259-262.
38. Pelham, W.E., Wheeler, T., & Chronis, A. (1998). Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology, 27, 190-205.
39. Perwien, A.R., Faries, D.E., Kratochvil, C.J., Sumner, C.R., Kelsey, D.K., & Allen, A.J. (2004). Improvement in health-related quality of life in children with ADHD: An analysis of placebo controlled studies of atomoxetine. Journal of Developmental and Behavioral Pediatrics, 25, 265-271.
40. Reich, W. (2000). Diagnostic Interview for Children and Adolescents (DICA). Journal of the American Academy of Child and Adolescent Psychiatry, 39, 59-66.
41. Rowe, K., & Rowe, K. (1997). Norms for parental ratings on Conners' Abbreviated Parent-Teacher Questionnaire: Implications for the design of behavioral rating inventories and analyses of data derived from them. Journal of Abnormal Child Psychology, 25, 425-451.
42. Sawyer, M.G., Whaites, L., Rey, J.M., Hazell, P.L., Graetz, B., & Baghurst, P. (2002). Health-related quality of life of children and adolescents with mental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 530-537.
43. Saylor, K.E., Buermeyer, C.M., Spencer, T.J., & Barkley, R.A. (2002). Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication. Journal of Clinical Psychiatry, 63, 23-28.
44. Sprague, R.L., & Sleator, E.K. (1973). Effects of psychopharmacological agents on learning disorders. Pediatric Clinics of North America, 20, 719-735.
45. Thurber, J.R., Heller, T.L., & Hinshaw, S.P. (2002). The social behaviors and peer expectation of girls with attention deficit hyperactivity disorder and comparison girls. Journal of Clinical Child and Adolescent Psychiatry, 31, 443-452.
46. Whalen, C.K., Henker, B., & Granger, D.A. (1989). Ratings of medication effects in hyperactive children: Viable or vulnerable ? Behavior Assessment, 11, 179-199.
47. Whalen, C.K., Henker, B., Jamner, L.D., Ishikawa, S.S., Floro, J.N., Swindle, R., et al. (2006). Toward mapping daily challenges of living with ADHD: Maternal and child perspectives using electronic diaries. Journal of Abnormal Child Psychology, 34, 1-16.
48. Wolraich, M.L., Lambert, E.W., Bickman, L., Simmons, T., Doffing, M.A., & Worley, K.A. (2004). Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 25, 41-47.